Clinical trial · Observational
Human Papillomavirus Screening and Vaccine Readiness Program
NCT00863096CI-TRIAL-00004502withdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Unable to get the vaccine on time to offer it to the study population.
Summary
Brief summary (as posted)
Public Health Research Institute (PHRI) is carrying out a 15 month research and advocacy project with the goals of generating critical data on acceptability, identifying determinants and facilitators of HPV vaccine uptake in adolescent girls; and investigating physicians' attitudes to identify predictors of intention to recommend immunization in Mysore, India.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Human Papilloma Virus-Related Carcinoma | Human Papillomavirus-Related Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Gardasil | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Gardasil
- interventionNames
- Biological: Gardasil
Primary outcomes (1)
- measure
- Acceptability of HPV vaccine
- timeFrame
- One year
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria * Potential participants must have at least one daughter between 8 and 14 years of age * Be a decision maker for the welfare of a girl aged 8-14 years * Be able to understand and give informed consent * Be able to speak Kannada
References
Publications (0)
Data not yet available
No reference posted for this study.